Sbc Medical Group Holdings Incorporated Revenue Growth Rates (SBC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Sbc Medical Group Holdings Incorporated  (NASDAQ: SBC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

SBC's Revenue Growth by Quarter and Year

Sbc Medical Group Holdings Incorporated's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SBC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 49.19
1st Quarter March 42.35
FY 91.54





SBC Revenue second quarter 2026 Y/Y Growth Comment
Sbc Medical Group Holdings Incorporated reported Revenue increase of 14.36% year on year in the second quarter 2026, to $ 49.19 millions, this is lower than Sbc Medical Group Holdings Incorporated's recent average Revenue surge of 39080.13%.

Looking into second quarter 2026 results within Healthcare Facilities industry 7 other companies have achieved higher Revenue growth. While Sbc Medical Group Holdings Incorporated' s Revenue growth of 14.36% ranks overall at the positon no. 1340 in the second quarter 2026.


SBC Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - -10.92 % -28.76 % -
3rd Quarter September - -18.43 % 10.49 % -
2nd Quarter June 14.36 % -19 % - -
1st Quarter March -9.37 % -14.74 % 273950 % -
FY   - -15.96 % 86.57 % -

Financial Statements
Sbc Medical Group Holdings Incorporated's second quarter 2026 Revenue $ 49.19 millions SBC's Income Statement
Sbc Medical Group Holdings Incorporated's second quarter 2025 Revenue $ 43.01 millions Quarterly SBC's Income Statement


SBC Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - -7.13 % -14.97 % 31.87 %
3rd Quarter September - -0.93 % -1.62 % -
2nd Quarter June 16.15 % -7.96 % -3.12 % -
1st Quarter March 7.03 % 5.2 % -12.09 % -
FY (Year on Year)   - -15.96 % 86.57 % -


Back to SBC Growth rate Comparisons >> Back to SBC Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #8
Healthcare Sector #239
Overall #1340

Revenue Y/Y Growth Statistics
High Average Low
351797.54 % 39080.13 % -28.76 %
(Jun 30 2026)   (Dec 31 2025)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #8
Healthcare Sector #239
Overall #1340
Revenue Y/Y Growth Statistics
High Average Low
351797.54 % 39080.13 % -28.76 %
(Jun 30 2026)   (Dec 31 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Sbc Medical Group Holdings Incorporated's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
31.88 % -7.3 % -100 %
(Dec 31 2023)  


SBC's II. Quarter Q/Q Revenue Comment
Sbc Medical Group Holdings Incorporated achieved in the II. Quarter 2026 above company average sequential Revenue jump of 16.15%, to $ 49.19 millions, from $42.35 millions in the first quarter.
SBC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Healthcare Facilities industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Sbc Medical Group Holdings Incorporated's Revenue growth quarter on quarter, overall rank is 608.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #5
Healthcare Sector #112
Overall #608
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #5
Healthcare Sector #112
Overall #608
Revenue Q/Q Growth Statistics
High Average Low
31.88 % -7.3 % -100 %
(Dec 31 2023)  


SBC's II. Quarter Q/Q Revenue Comment
Sbc Medical Group Holdings Incorporated achieved in the II. Quarter 2026 above company average sequential Revenue jump of 16.15%, to $ 49.19 millions, from $42.35 millions in the first quarter.
SBC is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Healthcare Facilities industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Sbc Medical Group Holdings Incorporated's Revenue growth quarter on quarter, overall rank is 608.


Sbc Medical Group Holdings Incorporated's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 173.71 $ 167.54 $ 171.92 $ 176.78 $ 186.40
Y / Y Revenue Growth (TTM) -6.81 % -14.74 % -15.96 % -20.55 % -14.31 %
Year on Year Revenue Growth Overall Ranking # 3554 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 3.69 % -2.55 % -2.75 % -5.16 % -5.14 %
Seq. Revenue Growth (TTM) Overall Ranking # 3014 # 2373 # 1953 # 0 # 0


Cumulative Revenue growth Comment
Sbc Medical Group Holdings Incorporated showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Sbc Medical Group Holdings Incorporated's annual Revenue decline would be -6.81% year on year to $174 millions.

In the Healthcare sector 489 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3554.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 34
Healthcare Sector # 490
Overall # 3554

Revenue TTM Y/Y Growth Statistics
High Average Low
-41.07 %
 -43.73 %
-45.07 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 414
S&P 500 # 3014
Cumulative Revenue growth Comment
Sbc Medical Group Holdings Incorporated showed decline, but improvement compare to trailing twelve month Revenue decrease in Mar 31 2026. If the fiscal year would end in Jun 30 2026, Sbc Medical Group Holdings Incorporated's annual Revenue drop would be -6.81% year on year to $174 millions.

In the Healthcare sector 489 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3554.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 34
Healthcare Sector # 490
Overall # 3554

Revenue TTM Y/Y Growth Statistics
High Average Low
-41.07 %
-43.73 %
-45.07 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 34
Sector # 414
S&P 500 # 3014




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SBC's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Radnet Inc 24.99%$ 24.986 millions
Precipio inc 24.18%$ 24.178 millions
Krystal Biotech Inc 24.14%$ 24.135 millions
Viemed Healthcare Inc 23.85%$ 23.853 millions
Ardelyx inc 23.77%$ 23.771 millions
Insulet Corporation23.51%$ 23.509 millions
Veracyte Inc 23.45%$ 23.448 millions
Journey Medical Corp23.33%$ 23.326 millions
Twist Bioscience Corporation23.24%$ 23.235 millions
Axogen inc 23.06%$ 23.065 millions
Vericel Corporation22.48%$ 22.481 millions
Milestone Scientific Inc 22.28%$ 22.276 millions
Alpha Teknova Inc 22.05%$ 22.045 millions
X4 Pharmaceuticals Inc21.64%$ 21.642 millions
Exagen Inc 21.63%$ 21.629 millions
Adaptive Biotechnologies Corporation21.53%$ 21.526 millions
Privia Health Group Inc 21.39%$ 21.390 millions
Bionano Genomics Inc 21.36%$ 21.357 millions
Evolus Inc 21.30%$ 21.298 millions
Invivyd Inc 21.20%$ 21.203 millions
Transmedics Group Inc 20.70%$ 20.702 millions
Irhythm Holdings Inc 20.62%$ 20.615 millions
Delcath Systems Inc 20.60%$ 20.604 millions
Castle Biosciences Inc 20.14%$ 20.140 millions
Procept Biorobotics Corporation20.00%$ 20.004 millions
Biomarin Pharmaceutical Inc19.91%$ 19.905 millions
Cannapharmarx Inc 19.26%$ 19.261 millions
Anika Therapeutics Inc 19.18%$ 19.176 millions
Bioaffinity Technologies Inc 18.99%$ 18.992 millions
Aurinia Pharmaceuticals Inc 18.87%$ 18.872 millions


About Sbc Medical Group Holdings Incorporated Revenue Growth Rates (SBC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Sbc Medical Group Holdings Inc (CIK 1930313).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-347843
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Sbc Medical Group Holdings Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.